{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T23:18:01Z","timestamp":1792883881484,"version":"4.5.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":50,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Vellore Institute of Technology, Vellore"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-57846-y","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T07:22:35Z","timestamp":1782112955000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Computational screening of antimicrobial peptide analogs targeting AdeB efflux transporter protein in Acinetobacter baumannii associated with multidrug resistance"],"prefix":"10.1038","volume":"16","author":[{"given":"Shalini","family":"Mathpal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushar","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romita","family":"Guchhait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudha","family":"Ramaiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Anbarasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"57846_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nrmicro.2017.148","volume":"16","author":"CM Harding","year":"2018","unstructured":"Harding, C. M., Hennon, S. W. & Feldman, M. F. Uncovering the mechanisms of Acinetobacter baumannii virulence. Nat. Rev. Microbiol. 16, 91\u2013102 (2018).","journal-title":"Nat. Rev. Microbiol."},{"key":"57846_CR2","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s00203-024-04107-z","volume":"206","author":"A Panickar","year":"2024","unstructured":"Panickar, A., Manoharan, A., Anbarasu, A. & Ramaiah, S. Respiratory tract infections: an update on the complexity of bacterial diversity, therapeutic interventions and breakthroughs. Arch. Microbiol. 206, 382 (2024).","journal-title":"Arch. Microbiol."},{"key":"57846_CR3","doi-asserted-by":"publisher","first-page":"291","DOI":"10.4103\/0974-777X.68538","volume":"2","author":"V Manchanda","year":"2010","unstructured":"Manchanda, V., Sanchaita, S. & Singh, N. Multidrug resistant Acinetobacter. J. Glob Infect. Dis. 2, 291 (2010).","journal-title":"J. Glob Infect. Dis."},{"key":"57846_CR4","doi-asserted-by":"publisher","first-page":"18203","DOI":"10.1038\/s41598-025-03246-7","volume":"15","author":"S Pearl","year":"2025","unstructured":"Pearl, S. & Anbarasu, A. Genomic landscape of nosocomial Acinetobacter baumannii: A comprehensive analysis of the resistome, virulome, and mobilome. Sci. Rep. 15, 18203 (2025).","journal-title":"Sci. Rep."},{"key":"57846_CR5","doi-asserted-by":"crossref","unstructured":"Appaneal, H. J., Lopes, V. V., LaPlante, K. L. & Caffrey, A. R. Treatment Clinical Outcomes, and Predictors of Mortality among a National Cohort of Admitted Patients with Acinetobacter baumannii Infection. Antimicrob Agents Chemother 66, e0197521 (2022).","DOI":"10.1128\/aac.01975-21"},{"key":"57846_CR6","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.3855\/jidc.16902","volume":"16","author":"ME Tokur","year":"2022","unstructured":"Tokur, M. E. et al. Mortality predictors on the day of healthcare-associated Acinetobacter baumanni bacteremia in intensive care unit. J. Infect. Dev. Ctries. 16, 1473\u20131481 (2022).","journal-title":"J. Infect. Dev. Ctries."},{"key":"57846_CR7","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli, E. et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect. Dis. 18, 318\u2013327 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"57846_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.compbiolchem.2016.12.001","volume":"67","author":"K Malathi","year":"2017","unstructured":"Malathi, K., Anbarasu, A. & Ramaiah, S. Exploring the resistance mechanism of imipenem in carbapenem hydrolysing class D beta-lactamases OXA-143 and its variant OXA-231 (D224A) expressing Acinetobacter baumannii: An in-silico approach. Comput. Biol. Chem. 67, 1\u20138 (2017).","journal-title":"Comput. Biol. Chem."},{"key":"57846_CR9","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.resmic.2011.02.006","volume":"162","author":"A Nemec","year":"2011","unstructured":"Nemec, A. et al. Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus\u2013Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU). Res. Microbiol. 162, 393\u2013404 (2011).","journal-title":"Res. Microbiol."},{"key":"57846_CR10","doi-asserted-by":"crossref","unstructured":"Vijayakumar, S. et al. Genomic investigation unveils colistin resistance mechanism in carbapenem-resistant Acinetobacter baumannii clinical isolates. Microbiol Spectr 12, e0251123 (2024).","DOI":"10.1128\/spectrum.02511-23"},{"key":"57846_CR11","doi-asserted-by":"publisher","first-page":"e0157757","DOI":"10.1371\/journal.pone.0157757","volume":"11","author":"B Fan","year":"2016","unstructured":"Fan, B., Guan, J., Wang, X. & Cong, Y. Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model. PLoS One. 11, e0157757 (2016).","journal-title":"PLoS One"},{"key":"57846_CR12","doi-asserted-by":"publisher","first-page":"e0150642","DOI":"10.1371\/journal.pone.0150642","volume":"11","author":"WY Kim","year":"2016","unstructured":"Kim, W. Y. et al. Comparable Efficacy of Tigecycline versus Colistin Therapy for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients. PLoS One. 11, e0150642 (2016).","journal-title":"PLoS One"},{"key":"57846_CR13","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ijantimicag.2016.06.006","volume":"48","author":"GG Rao","year":"2016","unstructured":"Rao, G. G. et al. Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumannii. Int. J. Antimicrob. Agents. 48, 331\u2013336 (2016).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"57846_CR14","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1097\/INF.0000000000004358","volume":"43","author":"S Vijayakumar","year":"2024","unstructured":"Vijayakumar, S. et al. Changing Landscape of Antimicrobial Resistance in Neonatal Sepsis: An in silico Analyses of Multidrug Resistance in Klebsiella pneumoniae. Pediatr. Infect. Dis. J. 43, 777\u2013784 (2024).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"57846_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.compbiomed.2014.02.009","volume":"48","author":"P Anitha","year":"2014","unstructured":"Anitha, P., Anbarasu, A. & Ramaiah, S. Computational gene network study on antibiotic resistance genes of Acinetobacter baumannii. Comput. Biol. Med. 48, 17\u201327 (2014).","journal-title":"Comput. Biol. Med."},{"key":"57846_CR16","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1093\/jac\/dkr082","volume":"66","author":"Y Chen","year":"2011","unstructured":"Chen, Y., Zhou, Z., Jiang, Y. & Yu, Y. Emergence of NDM-1-producing Acinetobacter baumannii in China. J. Antimicrob. Chemother. 66, 1255\u20131259 (2011).","journal-title":"J. Antimicrob. Chemother."},{"key":"57846_CR17","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1128\/CMR.00058-07","volume":"21","author":"AY Peleg","year":"2008","unstructured":"Peleg, A. Y., Seifert, H. & Paterson, D. L. Acinetobacter baumannii: Emergence of a Successful Pathogen. Clin. Microbiol. Rev. 21, 538\u2013582 (2008).","journal-title":"Clin. Microbiol. Rev."},{"key":"57846_CR18","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4067\/S0716-10182009000700002","volume":"26","author":"AC Opazo","year":"2009","unstructured":"Opazo, A. C., Mella, S. M., Dom\u00ednguez, M. Y., Bello, H. T. & Gonz\u00e1lez, G. R. [Multi-drug efflux pumps and antibiotic resistance in Acinetobacter baumannii]. Rev. Chil. Infectol. 26, 499\u2013503 (2009).","journal-title":"Rev. Chil. Infectol"},{"key":"57846_CR19","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrmicro1464","volume":"4","author":"LJV Piddock","year":"2006","unstructured":"Piddock, L. J. V. Multidrug-resistance efflux pumps ? not just for resistance. Nat. Rev. Microbiol. 4, 629\u2013636 (2006).","journal-title":"Nat. Rev. Microbiol."},{"key":"57846_CR20","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/ptr.8365","volume":"39","author":"S Ghosh","year":"2025","unstructured":"Ghosh, S., Basu, S., Anbarasu, A. & Ramaiah, S. A. Comprehensive Review of Antimicrobial Agents Against Clinically Important Bacterial Pathogens: Prospects for Phytochemicals. Phyther Res. 39, 138\u2013161 (2025).","journal-title":"Phyther Res."},{"key":"57846_CR21","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1128\/AAC.45.12.3375-3380.2001","volume":"45","author":"S Magnet","year":"2001","unstructured":"Magnet, S., Courvalin, P. & Lambert, T. Resistance-Nodulation-Cell Division-Type Efflux Pump Involved in Aminoglycoside Resistance in Acinetobacter baumannii Strain BM4454. Antimicrob. Agents Chemother. 45, 3375\u20133380 (2001).","journal-title":"Antimicrob. Agents Chemother."},{"key":"57846_CR22","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1128\/AAC.48.9.3298-3304.2004","volume":"48","author":"I Marchand","year":"2004","unstructured":"Marchand, I., Damier-Piolle, L., Courvalin, P. & Lambert, T. Expression of the RND-Type Efflux Pump AdeABC in Acinetobacter baumannii Is Regulated by the AdeRS Two-Component System. Antimicrob. Agents Chemother. 48, 3298\u20133304 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"57846_CR23","first-page":"241","volume":"50","author":"LJ Zhu","year":"2020","unstructured":"Zhu, L. J., Pan, Y., Gao, C. Y. & Hou, P. F. Distribution of Carbapenemases and Efflux Pump in Carbapenem-resistance Acinetobacter baumannii. Ann. Clin. Lab. Sci. 50, 241\u2013246 (2020).","journal-title":"Ann. Clin. Lab. Sci."},{"key":"57846_CR24","doi-asserted-by":"crossref","unstructured":"Wieczorek, P. et al. Multidrug resistant Acinetobacter baumannii\u2013the role of AdeABC (RND family) efflux pump in resistance to antibiotics. Folia Histochem. Cytobiol 46, 257\u2013267 (2008).","DOI":"10.2478\/v10042-008-0056-x"},{"key":"57846_CR25","doi-asserted-by":"crossref","unstructured":"Yoon, E. J. et al. Contribution of Resistance-Nodulation-Cell Division Efflux Systems to Antibiotic Resistance and Biofilm Formation in Acinetobacter baumannii. MBio 6, e00309\u201315 (2015).","DOI":"10.1128\/mBio.00309-15"},{"key":"57846_CR26","doi-asserted-by":"publisher","first-page":"103825","DOI":"10.1016\/j.micpath.2019.103825","volume":"139","author":"SN Abdi","year":"2020","unstructured":"Abdi, S. N. et al. AdeB efflux pump gene knockdown by mRNA mediated peptide nucleic acid in multidrug resistance Acinetobacter baumannii. Microb. Pathog. 139, 103825 (2020).","journal-title":"Microb. Pathog"},{"key":"57846_CR27","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3390\/pharmaceutics14040805","volume":"14","author":"J Hulme","year":"2022","unstructured":"Hulme, J. Application of Nanomaterials in the Prevention, Detection, and Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA). Pharmaceutics 14, 805 (2022).","journal-title":"Pharmaceutics"},{"key":"57846_CR28","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4292\/wjgpt.v8.i3.162","volume":"8","author":"DM Lin","year":"2017","unstructured":"Lin, D. M., Koskella, B. & Lin, H. C. Phage therapy: An alternative to antibiotics in the age of multi-drug resistance. World J. Gastrointest. Pharmacol. Ther. 8, 162\u2013173 (2017).","journal-title":"World J. Gastrointest. Pharmacol. Ther."},{"key":"57846_CR29","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00203-025-04483-0","volume":"207","author":"EA George","year":"2025","unstructured":"George, E. A., Naha, A. & Ramaiah, S. Novel antimicrobial peptide HFIAP-1 mutant as a \u03b2-lactamase inhibitor against extended-spectrum \u03b2-lactamases of Escherichia coli: a comprehensive in-silico approach. Arch. Microbiol. 207, 279 (2025).","journal-title":"Arch. Microbiol."},{"key":"57846_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s12602-025-10608-0","author":"EA George","year":"2025","unstructured":"George, E. A. et al. Pharmacokinetics Screening, Molecular Docking, and Dynamics Simulations Revealed Novel Antimicrobial Peptide NKLF2 Mutants as Potent Inhibitors of Mycobacterium tuberculosis. Probiotics Antimicrob. Proteins. https:\/\/doi.org\/10.1007\/s12602-025-10608-0 (2025).","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"57846_CR31","doi-asserted-by":"publisher","first-page":"107151","DOI":"10.1016\/j.bioorg.2024.107151","volume":"145","author":"A Mulukutla","year":"2024","unstructured":"Mulukutla, A. et al. Recent advances in antimicrobial peptide-based therapy. Bioorg. Chem. 145, 107151 (2024).","journal-title":"Bioorg. Chem."},{"key":"57846_CR32","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1021\/acsomega.4c07176","volume":"10","author":"U Nagarajan","year":"2025","unstructured":"Nagarajan, U. et al. Biomolecular Interaction of Carnosine and Anti-TB Drug: Preparation of Functional Biopeptide-Based Nanocomposites and Characterization through In Vitro and In Silico Investigations. ACS Omega. 10, 567\u2013587 (2025).","journal-title":"ACS Omega"},{"key":"57846_CR33","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1016\/j.peptides.2011.08.015","volume":"32","author":"CH Lin","year":"2011","unstructured":"Lin, C. H., Tzen, J. T. C., Shyu, C. L., Yang, M. J. & Tu, W. C. Structural and biological characterization of mastoparans in the venom of Vespa species in Taiwan. Peptides 32, 2027\u20132036 (2011).","journal-title":"Peptides"},{"key":"57846_CR34","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.3390\/antibiotics13121147","volume":"13","author":"N Roson-Calero","year":"2024","unstructured":"Roson-Calero, N. et al. Cyclic Peptide MV6, an Aminoglycoside Efficacy Enhancer Against Acinetobacter baumannii. Antibiotics 13, 1147 (2024).","journal-title":"Antibiotics"},{"key":"57846_CR35","doi-asserted-by":"crossref","unstructured":"R\u00fchl-Teichner, J. et al. Inhibitory Effect of Antimicrobial Peptides Bac7(17), PAsmr5-17 and PA\u03b2N on Bacterial Growth and Biofilm Formation of Multidrug-Resistant Acinetobacter baumannii. Microorganisms 13, 639 (2025).","DOI":"10.3390\/microorganisms13030639"},{"key":"57846_CR36","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.3390\/ph16091281","volume":"16","author":"K Rangel","year":"2023","unstructured":"Rangel, K., Lechuga, G. C., Provance, D. W., Morel, C. M. & De Simone, S. G. An Update on the Therapeutic Potential of Antimicrobial Peptides against Acinetobacter baumannii Infections. Pharmaceuticals 16, 1281 (2023).","journal-title":"Pharmaceuticals"},{"key":"57846_CR37","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1016\/j.bbagen.2018.06.011","volume":"1862","author":"WF Porto","year":"2018","unstructured":"Porto, W. F., Fensterseifer, I. C. M., Ribeiro, S. M. & Franco, O. L. Joker: An algorithm to insert patterns into sequences for designing antimicrobial peptides. Biochim. Biophys. Acta - Gen. Subj. 1862, 2043\u20132052 (2018).","journal-title":"Biochim. Biophys. Acta - Gen. Subj."},{"key":"57846_CR38","doi-asserted-by":"crossref","unstructured":"Cao, Q. et al. Designing antimicrobial peptides using deep learning and molecular dynamic simulations. Brief Bioinform 24, bbad058 (2023).","DOI":"10.1093\/bib\/bbad058"},{"key":"57846_CR39","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/pro.3714","volume":"29","author":"FH Waghu","year":"2020","unstructured":"Waghu, F. H. & Idicula-Thomas, S. Collection of antimicrobial peptides database and its derivatives: Applications and beyond. Protein Sci. 29, 36\u201342 (2020).","journal-title":"Protein Sci."},{"key":"57846_CR40","doi-asserted-by":"publisher","first-page":"D1087","DOI":"10.1093\/nar\/gkv1278","volume":"44","author":"G Wang","year":"2016","unstructured":"Wang, G., Li, X. & Wang, Z. APD3: the antimicrobial peptide database as a tool for research and education. Nucleic Acids Res. 44, D1087\u2013D1093 (2016).","journal-title":"Nucleic Acids Res."},{"key":"57846_CR41","doi-asserted-by":"publisher","first-page":"W288","DOI":"10.1093\/nar\/gks419","volume":"40","author":"P Thevenet","year":"2012","unstructured":"Thevenet, P. et al. PEP-FOLD: an updated de novo structure prediction server for both linear and disulfide bonded cyclic peptides. Nucleic Acids Res. 40, W288\u2013W293 (2012).","journal-title":"Nucleic Acids Res."},{"key":"57846_CR42","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1093\/nar\/gkg563","volume":"31","author":"E Gasteiger","year":"2003","unstructured":"Gasteiger, E. ExPASy: the proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res. 31, 3784\u20133788 (2003).","journal-title":"Nucleic Acids Res."},{"key":"57846_CR43","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1479-5876-11-74","volume":"11","author":"A Gautam","year":"2013","unstructured":"Gautam, A. et al. In silico approaches for designing highly effective cell penetrating peptides. J. Transl Med. 11, 74 (2013).","journal-title":"J. Transl Med."},{"key":"57846_CR44","doi-asserted-by":"publisher","first-page":"108926","DOI":"10.1016\/j.compbiomed.2024.108926","volume":"179","author":"AS Rathore","year":"2024","unstructured":"Rathore, A. S., Choudhury, S., Arora, A., Tijare, P. & Raghava, G. P. ToxinPred 3.0: An improved method for predicting the toxicity of peptides. Comput. Biol. Med. 179, 108926 (2024).","journal-title":"Comput. Biol. Med."},{"key":"57846_CR45","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1007\/s00894-014-2278-5","volume":"20","author":"I Dimitrov","year":"2014","unstructured":"Dimitrov, I., Bangov, I., Flower, D. R. & Doytchinova, I. AllerTOP v.2\u2014a server for in silico prediction of allergens. J. Mol. Model. 20, 2278 (2014).","journal-title":"J. Mol. Model."},{"key":"57846_CR46","doi-asserted-by":"crossref","unstructured":"Khatun, M. S., Hasan, M. M. & Kurata, H. PreAIP: Computational Prediction of Anti-inflammatory Peptides by Integrating Multiple Complementary Features. Front Genet 10, 129 (2019).","DOI":"10.3389\/fgene.2019.00129"},{"key":"57846_CR47","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2105-8-4","volume":"8","author":"IA Doytchinova","year":"2007","unstructured":"Doytchinova, I. A. & Flower, D. R. VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinform. 8, 4 (2007).","journal-title":"BMC Bioinform."},{"key":"57846_CR48","doi-asserted-by":"publisher","first-page":"22843","DOI":"10.1038\/srep22843","volume":"6","author":"K Chaudhary","year":"2016","unstructured":"Chaudhary, K. et al. A Web Server and Mobile App for Computing Hemolytic Potency of Peptides. Sci. Rep. 6, 22843 (2016).","journal-title":"Sci. Rep."},{"key":"57846_CR49","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nprot.2016.169","volume":"12","author":"D Kozakov","year":"2017","unstructured":"Kozakov, D. et al. The ClusPro web server for protein\u2013protein docking. Nat. Protoc. 12, 255\u2013278 (2017).","journal-title":"Nat. Protoc."},{"key":"57846_CR50","doi-asserted-by":"publisher","first-page":"D370","DOI":"10.1093\/nar\/gkr703","volume":"40","author":"MA Lomize","year":"2012","unstructured":"Lomize, M. A., Pogozheva, I. D., Joo, H., Mosberg, H. I. & Lomize, A. L. OPM database and PPM web server: resources for positioning of proteins in membranes. Nucleic Acids Res. 40, D370\u2013D376 (2012).","journal-title":"Nucleic Acids Res."},{"key":"57846_CR51","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s42003-021-02318-4","volume":"4","author":"D Mann","year":"2021","unstructured":"Mann, D. et al. Structure and lipid dynamics in the maintenance of lipid asymmetry inner membrane complex of A. baumannii. Commun. Biol. 4, 817 (2021).","journal-title":"Commun. Biol."},{"key":"57846_CR52","doi-asserted-by":"publisher","first-page":"126109","DOI":"10.1016\/j.ijbiomac.2023.126109","volume":"250","author":"Y Tuo","year":"2023","unstructured":"Tuo, Y. et al. Virtual screening and biological activity evaluation of novel efflux pump inhibitors targeting AdeB. Int. J. Biol. Macromol. 250, 126109 (2023).","journal-title":"Int. J. Biol. Macromol."},{"key":"57846_CR53","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1529\/biophysj.104.048835","volume":"88","author":"K Murzyn","year":"2005","unstructured":"Murzyn, K., R\u00f3g, T. & Pasenkiewicz-Gierula, M. Phosphatidylethanolamine-Phosphatidylglycerol Bilayer as a Model of the Inner Bacterial Membrane. Biophys. J. 88, 1091\u20131103 (2005).","journal-title":"Biophys. J."},{"key":"57846_CR54","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1002\/jcc.23702","volume":"35","author":"EL Wu","year":"2014","unstructured":"Wu, E. L. et al. CHARMM-GUI Membrane Builder toward realistic biological membrane simulations. J. Comput. Chem. 35, 1997\u20132004 (2014).","journal-title":"J. Comput. Chem."},{"key":"57846_CR55","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/jcc.21367","volume":"31","author":"K Vanommeslaeghe","year":"2010","unstructured":"Vanommeslaeghe, K. et al. CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. J. Comput. Chem. 31, 671\u2013690 (2010).","journal-title":"J. Comput. Chem."},{"key":"57846_CR56","doi-asserted-by":"publisher","first-page":"6794","DOI":"10.1038\/s41598-024-57124-9","volume":"14","author":"K Nyambo","year":"2024","unstructured":"Nyambo, K. et al. Molecular docking, molecular dynamics simulations and binding free energy studies of interactions between Mycobacterium tuberculosis Pks13, PknG and bioactive constituents of extremophilic bacteria. Sci. Rep. 14, 6794 (2024).","journal-title":"Sci. Rep."},{"key":"57846_CR57","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s44371-025-00130-1","volume":"2","author":"BT Ogunyemi","year":"2025","unstructured":"Ogunyemi, B. T. et al. Protein\u2013ligand molecular dynamics simulation (PL-MDS), ADMET analyses, and bioactivity studies of phytochemicals from Aloe Vera: an In-Silico novel antidiabetics drug discovery effort. Discov Chem. 2, 55 (2025).","journal-title":"Discov Chem."},{"key":"57846_CR58","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","volume":"17","author":"MS Vald\u00e9s-Tresanco","year":"2021","unstructured":"Vald\u00e9s-Tresanco, M. S., Vald\u00e9s-Tresanco, M. E., Valiente, P. A. & Moreno, E. gmx_MMPBSA A New Tool to Perform End-State Free Energy Calculations with GROMACS. J. Chem. Theory Comput. 17, 6281\u20136291 (2021).","journal-title":"J. Chem. Theory Comput."},{"key":"57846_CR59","doi-asserted-by":"crossref","unstructured":"Leus, I. V., Roberts, S. R., Trinh, A., Yu, W. & Zgurskaya, H. E. I. Nonadditive functional interactions between ligand-binding sites of the multidrug efflux pump AdeB from Acinetobacter baumannii. J Bacteriol 206, e0021723 (2024).","DOI":"10.1128\/jb.00217-23"},{"key":"57846_CR60","doi-asserted-by":"crossref","unstructured":"Morgan, C. E. et al. Cryoelectron Microscopy Structures of AdeB Illuminate Mechanisms of Simultaneous Binding and Exporting of Substrates. MBio 12, e03690\u201320 (2021).","DOI":"10.1128\/mBio.03690-20"},{"key":"57846_CR61","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1128\/CMR.00117-14","volume":"28","author":"XZ Li","year":"2015","unstructured":"Li, X. Z., Pl\u00e9siat, P. & Nikaido, H. The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria. Clin. Microbiol. Rev. 28, 337\u2013418 (2015).","journal-title":"Clin. Microbiol. Rev."},{"key":"57846_CR62","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13568-022-01444-4","volume":"12","author":"E Rafiei","year":"2022","unstructured":"Rafiei, E., Shahini Shams Abadi, M., Zamanzad, B. & Gholipour, A. The frequency of efflux pump genes expression in Acinetobacter baumannii isolates from pulmonary secretions. AMB Express. 12, 103 (2022).","journal-title":"AMB Express"},{"key":"57846_CR63","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4103\/jgid.jgid_404_20","volume":"13","author":"S Raza","year":"2021","unstructured":"Raza, S. et al. Molecular Characterization of Resistance-Nodulation-cell Division Efflux Pump Genes in Multidrug-Resistant Acinetobacter baumannii. J. Glob Infect. Dis. 13, 177\u2013179 (2021).","journal-title":"J. Glob Infect. Dis."},{"key":"57846_CR64","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1002\/prot.26539","volume":"91","author":"MR Shakibaie","year":"2023","unstructured":"Shakibaie, M. R., Modaresi, F., Azizi, O., Tadjrobehkar, O. & Ghaemi, M. M. Amphiphilic peptide Mastoparan-B induces conformational changes within the AdeB efflux pump, down-regulates adeB gene expression, and restores antibiotic susceptibility in an MDR strain of Acinetobacter baumannii. Proteins Struct. Funct. Bioinforma. 91, 1205\u20131221 (2023).","journal-title":"Proteins Struct. Funct. Bioinforma"},{"key":"57846_CR65","doi-asserted-by":"publisher","first-page":"977","DOI":"10.2147\/DDDT.S405579","volume":"17","author":"J Peng","year":"2023","unstructured":"Peng, J. et al. Antimicrobial Peptide Cec4 Eradicates Multidrug-Resistant Acinetobacter baumannii in vitro and in vivo. Drug Des. Devel Ther. 17, 977\u2013992 (2023).","journal-title":"Drug Des. Devel Ther."},{"key":"57846_CR66","doi-asserted-by":"publisher","first-page":"8140","DOI":"10.1021\/acs.jmedchem.9b00915","volume":"62","author":"KGN Oshiro","year":"2019","unstructured":"Oshiro, K. G. N. et al. Computer-Aided Design of Mastoparan-like Peptides Enables the Generation of Nontoxic Variants with Extended Antibacterial Properties. J. Med. Chem. 62, 8140\u20138151 (2019).","journal-title":"J. Med. Chem."},{"key":"57846_CR67","doi-asserted-by":"crossref","unstructured":"Khabaz, H., Rahimi-Nasrabadi, M. & Keihan, A. H. Hierarchical machine learning model predicts antimicrobial peptide activity against Staphylococcus aureus. Front Mol. Biosci 10, 1238509 (2023).","DOI":"10.3389\/fmolb.2023.1238509"},{"key":"57846_CR68","doi-asserted-by":"publisher","first-page":"107800","DOI":"10.1016\/j.compbiolchem.2022.107800","volume":"102","author":"A Al-Khdhairawi","year":"2023","unstructured":"Al-Khdhairawi, A. et al. Machine learning and molecular simulation ascertain antimicrobial peptide against Klebsiella pneumoniae from public database. Comput. Biol. Chem. 102, 107800 (2023).","journal-title":"Comput. Biol. Chem."},{"key":"57846_CR69","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.3390\/molecules30153070","volume":"30","author":"M del Olmo","year":"2025","unstructured":"del Olmo, M. & Andreu, C. Current Status of the Application of Antimicrobial Peptides and Their Conjugated Derivatives. Molecules 30, 3070 (2025).","journal-title":"Molecules"},{"key":"57846_CR70","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1038\/s41598-024-51716-1","volume":"14","author":"S He","year":"2024","unstructured":"He, S. & Deber, C. M. Interaction of designed cationic antimicrobial peptides with the outer membrane of gram-negative bacteria. Sci. Rep. 14, 1894 (2024).","journal-title":"Sci. Rep."},{"key":"57846_CR71","doi-asserted-by":"crossref","unstructured":"de Santana, C. J. C. et al. Mastoparans: A Group of Multifunctional \u03b1-Helical Peptides With Promising Therapeutic Properties. Front Mol. Biosci 9, 824989 (2022).","DOI":"10.3389\/fmolb.2022.824989"},{"key":"57846_CR72","doi-asserted-by":"publisher","first-page":"6919","DOI":"10.1038\/s41467-021-27146-2","volume":"12","author":"A Ornik-Cha","year":"2021","unstructured":"Ornik-Cha, A. et al. Structural and functional analysis of the promiscuous AcrB and AdeB efflux pumps suggests different drug binding mechanisms. Nat. Commun. 12, 6919 (2021).","journal-title":"Nat. Commun."},{"key":"57846_CR73","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1007\/s00726-016-2266-4","volume":"48","author":"M Mardirossian","year":"2016","unstructured":"Mardirossian, M. et al. In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections. Amino Acids. 48, 2253\u20132260 (2016).","journal-title":"Amino Acids"},{"key":"57846_CR74","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/j.peptides.2003.07.025","volume":"24","author":"M Benincasa","year":"2003","unstructured":"Benincasa, M., Skerlavaj, B., Gennaro, R., Pellegrini, A. & Zanetti, M. In vitro and in vivo antimicrobial activity of two \u03b1-helical cathelicidin peptides and of their synthetic analogs. Peptides 24, 1723\u20131731 (2003).","journal-title":"Peptides"},{"key":"57846_CR75","doi-asserted-by":"publisher","first-page":"7318","DOI":"10.1038\/s41598-021-86844-5","volume":"11","author":"CJ Jung","year":"2021","unstructured":"Jung, C. J. et al. Identification of potential therapeutic antimicrobial peptides against Acinetobacter baumannii in a mouse model of pneumonia. Sci. Rep. 11, 7318 (2021).","journal-title":"Sci. Rep."},{"key":"57846_CR76","doi-asserted-by":"publisher","first-page":"14719","DOI":"10.1074\/jbc.M608920200","volume":"282","author":"J Andra\u00f6","year":"2007","unstructured":"Andra\u00f6, J. et al. Rationale for the Design of Shortened Derivatives of the NK-lysin-derived Antimicrobial Peptide NK-2 with Improved Activity against Gram-negative Pathogens. J. Biol. Chem. 282, 14719\u201314728 (2007).","journal-title":"J. Biol. Chem."},{"key":"57846_CR77","doi-asserted-by":"crossref","unstructured":"de Breij, A. et al. The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms. Sci Transl Med 10, eaan4044 (2018).","DOI":"10.1126\/scitranslmed.aan4044"},{"key":"57846_CR78","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s12602-023-10067-5","volume":"16","author":"A Naha","year":"2024","unstructured":"Naha, A. & Ramaiah, S. Novel Antimicrobial Peptide SAAP Mutant as a Better Adjuvant to Sulbactam-Based Treatments Against Clinical Strains of XDR Acinetobacter baumannii. Probiotics Antimicrob. Proteins. 16, 459\u2013473 (2024).","journal-title":"Probiotics Antimicrob. Proteins"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57846-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57846-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57846-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T14:03:39Z","timestamp":1786457019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57846-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["57846"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-57846-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"23 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Studies in human and animals","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Informed consent and patient details","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":6,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"24936"}}